Working... Menu
Trial record 34 of 401 for:    bleeding episodes

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02172950
Recruitment Status : Recruiting
First Posted : June 24, 2014
Last Update Posted : July 4, 2019
Information provided by (Responsible Party):
CSL Behring

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 29, 2022
  Estimated Study Completion Date : July 29, 2022